Leachables Risk from Desiccants, Canisters, and Closure Liners


Published on 03/05/2026

Managing Leachables Risks from Desiccants and Closure Liners in Pharmaceutical Packaging

Pharmaceutical manufacturing professionals face numerous challenges when selecting desiccants, canisters, and closure liners for packaging. A critical concern is the risk of leachables, which can compromise product quality and patient safety. This article will equip you with practical strategies for identifying symptoms of leachables issues, implementing effective containment measures, conducting thorough investigations, and establishing a sustainable corrective action plan.

By understanding the failure modes associated with desiccants and closure liners, you will be empowered to perform comprehensive risk assessments in your packaging processes, ensuring compliance with regulatory expectations and safeguarding product integrity.

Symptoms/Signals on the Floor or in the Lab

A variety of signals may indicate issues related to leachables in pharmaceutical packaging. These can arise during routine checks, quality control assessments, or development studies. Key symptoms include:

  • Unexpected Product Degradation: Reduction in active ingredient potency or alterations in chemical stability.
  • Changes in Physical Properties: Variations in color, odor, or appearance of the product.
  • Contaminant Detection: Identification of unexpected compounds during stability testing or routine
analysis.
  • Customer Complaints: Reports of adverse reactions or product failures from end-users.
  • Failure in Packaging Integrity: Leaks or pressure loss in sealed canisters or containers.
  • Detecting these symptoms early can significantly reduce the risks associated with leachables. It is crucial to align your detection methods with regulatory criteria to validate your findings.

    Likely Causes

    Understanding the root causes of leachables is essential for effective remediation. Causes can generally fall into six categories: Materials, Method, Machine, Man, Measurement, and Environment. Below is a breakdown of each category with relevant causes:

    Category Possible Causes
    Materials Incompatible desiccants or closure liners, low-quality polymers, or additives in packaging materials.
    Method Improper packaging techniques, inadequate sealing processes, or faulty production protocols.
    Machine Poorly maintained or calibrated equipment that could alter temperature or humidity conditions.
    Man Insufficient training and awareness of staff regarding potential leachables risks associated with materials.
    Measurement Inaccurate or outdated analytical techniques for monitoring leachables.
    Environment Extreme temperature fluctuations or excessive humidity during storage and transport.

    Each of these categories provides a framework for brainstorming potential causes and should guide the investigation process.

    Immediate Containment Actions (first 60 minutes)

    In the event of a suspected leachables issue, prompt action is required. Initial containment actions must be executed within the first 60 minutes to mitigate risks. Suggested actions include:

    • Isolate Affected Batch: Immediately halt distribution and use of the implicated product. Segregate all batches in conjunction with established SOPs.
    • Document Findings: Begin detailed logging of symptoms observed, including dates, times, and personnel involved.
    • Notify Key Stakeholders: Alert management, quality assurance, and compliance teams to ensure transparency and action.
    • Initiate Sampling and Testing: Collect samples of the product, packaging materials, and any relevant components for analysis.

    These containment measures will help prevent the escalation of the issue and lay the groundwork for further investigation.

    Investigation Workflow

    A robust investigation workflow is integral to uncovering the root cause of leachables. This process will typically involve the following steps:

    1. Data Collection: Gather comprehensive data including all analytical results, batch records, production environment conditions, and vendor information related to materials.
    2. Interviews: Conduct interviews with personnel involved in handling and packaging the affected products to gather qualitative insights.
    3. Historical Review: Examine previous batches and their outcomes to determine patterns or recurring issues that may indicate systemic problems.
    4. Analysis of Testing Results: Compare results of leachables testing against established toxicity thresholds and regulatory guidelines.

    After completing these steps, it is critical to synthesize your findings to guide subsequent root cause analysis.

    Root Cause Tools

    Effective root cause analysis employs several established tools. Below, we summarize three widely used methodologies and their optimal applications:

    • 5-Why Analysis: This simple technique encourages teams to ask “Why?” at least five times to drill down into the cause of the problem. It’s effective for relatively straightforward issues.
    • Fishbone Diagram (Ishikawa): This visual form categorizes potential causes into broad headings, allowing teams to brainstorm systematically. It is particularly useful when the cause is multifaceted and involves many potential contributors.
    • Fault Tree Analysis: This deductive reasoning method is more complex and beneficial for problems that require deep technical investigation. It maps out failure paths leading to a specific fault.

    Select the tool that best fits the complexity of your issue while ensuring adequate cross-functional team involvement during the analysis phase.

    CAPA Strategy

    Once root causes have been identified, an effective CAPA strategy should be initiated, which encompasses:

    • Correction: Immediate actions to correct the identified problem should be implemented to ensure affected products are not distributed.
    • Corrective Action: Focus on addressing root causes to prevent recurrence, such as reviewing vendor specifications or enhancing training protocols for personnel.
    • Preventive Action: Develop additional monitoring or risk assessment strategies to proactively manage leachables risks. This might involve regular audits of suppliers and inclusion of stability indicators in product development.

    Document each step meticulously, as a detailed CAPA plan will provide a direct pathway for effective resolution and compliance during inspections.

    Control Strategy & Monitoring

    Implementing a control strategy is critical to maintaining product quality while managing leachables risks. Key components of a robust strategy include:

    • Statistical Process Control (SPC): Utilize SPC techniques to monitor production processes. Regularly analyze variability that may indicate risks to product quality.
    • Sampling Procedures: Establish a systematic sampling plan for both incoming materials and final products to regularly assess leachables levels.
    • Alarm Systems: Integrate real-time monitoring systems that trigger alerts when conditions deviate from established parameters, allowing for quick remediation.
    • Verification Processes: Schedule periodic verification of the entire packaging process and material components as part of the quality assurance program.

    These monitoring points will help sustain a controlled environment and minimize the risks associated with leachables.

    Related Reads

    Validation / Re-qualification / Change Control impact

    When significant changes are made to materials or processes that impact packaging, such as a change in material suppliers, rigorous validation, re-qualification, and change control procedures are essential. This includes:

    • Validation Plans: Define validation criteria that align with regulatory expectations focusing on leachables testing methodologies.
    • Re-qualification: Carry out re-qualification for processes impacted by these changes, including stability studies to assess the impact on product quality.
    • Change Control Procedures: Ensure all changes are recorded within a robust change control system, detailing risk assessments and subsequent outcomes of each change.

    Clearly defining the necessity for validation and change control will align your processes with regulatory frameworks and enhance inspection readiness.

    Inspection Readiness: what evidence to show

    To prepare for inspections regarding leachables, ensure the following evidentiary elements are readily available:

    • Records: Comprehensive records of all batch testing and analytical results, including past and current leachables data.
    • Logs: Documentation of environmental conditions during storage and transport of product batches, as well as any deviations noted.
    • Batch Documentation: Complete batch production records, including materials used, production parameters, and quality control checks.
    • Deviation Reports: Detailed documentation of any deviations encountered during the production or quality control process, including CAPA results.

    By having these documents in order, your facility will demonstrate a proactive approach to managing leachables risks and will be well-prepared for regulatory scrutiny.

    FAQs

    What are leachables?

    Leachables are substances that migrate from packaging materials into drug products, potentially affecting their quality and safety.

    How can I identify leachables during stability testing?

    Leachables can be identified through rigorous testing using techniques like mass spectrometry or chromatography to assess the chemical composition of the drug product over time.

    What factors should I consider when selecting desiccants for packaging?

    Consider factors such as compatibility with drug compounds, absorption capacity, potential for chemical migration, and regulatory compliance.

    How often should I conduct leachables testing?

    Leachables testing should be a part of your regular Quality Assurance protocols, especially for high-risk products, or during significant changes to packaging materials.

    What guidelines should I follow for leachables risk assessment?

    Follow guidelines set forth by the ICH Q3A and ICH Q3C, which provide frameworks for assessing impurities including leachables.

    Can leachables from desiccants affect drug stability?

    Yes, leachables can interact with active pharmaceutical ingredients, potentially leading to degradation and loss of efficacy.

    What role do regulatory bodies play in leachables assessments?

    Regulatory bodies like the FDA and EMA provide guidance on acceptable limits for leachables and require compliance to ensure patient safety.

    How do I ensure compliance with E&L guidelines?

    Document all processes related to extractables and leachables, and ensure that testing protocols align with international regulatory standards.

    What are the consequences of non-compliance regarding leachables?

    Non-compliance can lead to product recalls, regulatory fines, and erosion of trust from customers and stakeholders.

    How can I improve employee training on leachables?

    Regularly conduct training sessions emphasizing the importance of leachables risks, detection methods, and compliance requirements.

    What resources exist for further study on leachables?

    Visit guidelines from organizations such as the FDA, EMA, and ICH for comprehensive insights and recommendations on managing leachables in pharmaceutical packaging.

    Pharma Tip:  How to Manage E&L Risks During Supplier Qualification